Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Barclays analyst Christopher Pasquale initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight rating and announces Price Target of $100.
Barclays analyst Christopher Pasquale initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight rating and announces Price Target of $100.